These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 3861965)

  • 21. Serum fructosamine and glycated haemoglobin measurements in diabetic control.
    Hindle EJ; Rostron GM; Clark SA; Gatt JA
    Arch Dis Child; 1986 Feb; 61(2):113-7. PubMed ID: 3954436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fructosamine assay: an index of medium-term metabolic control parameters in diabetic disease.
    Lapolla A; Poli T; Barison A; Fedele D
    Diabetes Res Clin Pract; 1988 Feb; 4(3):231-5. PubMed ID: 3359924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus.
    Baker JR; O'Connor JP; Metcalf PA; Lawson MR; Johnson RN
    Br Med J (Clin Res Ed); 1983 Sep; 287(6396):863-7. PubMed ID: 6412861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycated blood proteins in canine diabetes mellitus.
    Jensen AL
    Vet Rec; 1995 Oct; 137(16):401-5. PubMed ID: 8545938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of fructosamine with glycosylated hemoglobin and plasma proteins as measures of glycemic control.
    Smart LM; Howie AF; Young RJ; Walker SW; Clarke BF; Smith AF
    Diabetes Care; 1988 May; 11(5):433-6. PubMed ID: 3391095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fructosamine: an alternative assessment of past glycaemic control in developing countries.
    Islam N; Akhter J; Kayani N; Khan MA
    J Pak Med Assoc; 1993 Nov; 43(11):238-40. PubMed ID: 8114262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Routine control of type 2 diabetes. Are glycosylated hemoglobin and fructosamine measurements necessary?].
    Tryggeseth A
    Tidsskr Nor Laegeforen; 1990 Aug; 110(19):2539-40. PubMed ID: 2219017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Levels of fasting blood glucose and serum fructosamine for monitoring of glucose control in patients with non-insulin-dependent diabetes mellitus].
    Mercelina LF; Degenaar CP; Nieuwenhuijzen Kruseman AC
    Ned Tijdschr Geneeskd; 1989 Sep; 133(38):1887-90. PubMed ID: 2797305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of serum fructosamine activity in type I diabetic children.
    Cefalu WT; Mejia E; Puente GR; Fleishhacker D; Macaulay K
    Am J Med Sci; 1989 Apr; 297(4):244-6. PubMed ID: 2705464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of hyperlipoproteinemia on serum fructosamine].
    Drexel H; Patsch JR
    Wien Klin Wochenschr Suppl; 1990; 180():24-32; discussion 32-3. PubMed ID: 2321387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum fructosamine level as a marker of glycemic control in diabetic patients with and without a residual C-peptide secretion.
    Buysschaert M; Ketelslegers JM; Mpoy M; Galanti L; Pirson F; Pouthier F; Lambert AE
    Diabetes Res; 1987 Nov; 6(3):129-31. PubMed ID: 3436113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Practical value of serum fructosamine determination in diabetes mellitus].
    Pátkay J; Inkei J; Biró A; Berki A; Bereczki Z
    Orv Hetil; 1985 Dec; 126(51):3147-8, 3151-2. PubMed ID: 4080376
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lipoprotein and apolipoprotein levels in young insulin-dependent diabetic patients. Relations with glycosylated hemoglobin and fructosamine].
    Willems D; Dorchy H
    Presse Med; 1990 Jan 6-13; 19(1):17-20. PubMed ID: 2137219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of low glycaemic index foods improves metabolic control of diabetic patients over five weeks.
    Fontvieille AM; Rizkalla SW; Penfornis A; Acosta M; Bornet FR; Slama G
    Diabet Med; 1992 Jun; 9(5):444-50. PubMed ID: 1611832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An analysis of glycosylated blood proteins and blood glucose profiles over one year in patients with type 1 diabetes.
    Winocour PH; Bhatnagar D; Kalsi P; Hillier VF; Anderson DC
    Diabet Med; 1989 Nov; 6(8):709-16. PubMed ID: 2532106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Correlations of the levels of HbA1c with plasma apoproteins and plasma lipoproteins in type II diabetic patients].
    Ródenas S; Sánchez-Cabezudo M; Cuesta C
    Rev Esp Fisiol; 1993 Mar; 49(1):23-9. PubMed ID: 8378574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of serum fructosamine and blood glucose concentrations as indices of glycaemic control in non-insulin dependent diabetic out-patients.
    Lim TO; Selvan T; Suppiah A; Khan N; Ismail F
    Singapore Med J; 1992 Jun; 33(3):287-9. PubMed ID: 1631590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum fructosamine correlates with gingival index in children with insulin-dependent diabetes mellitus (IDDM).
    Firatli E; Unal T; Saka N; Onan U; Sivas A; Oz H
    J Clin Periodontol; 1994 Sep; 21(8):565-8. PubMed ID: 7989622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum fructosamine concentrations in patients with type II (non-insulin-dependent) diabetes mellitus during changes in management.
    Baker JR; Johnson RN; Scott DJ
    Br Med J (Clin Res Ed); 1984 May; 288(6429):1484-6. PubMed ID: 6426612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.